IAVI

Search Results

Press Releases

IAVI and the Biomedical Advanced Research and Development Authority partner to advance filovirus vaccine candidates

October 27, 2021

NEW YORK – OCTOBER 27, 2021 – IAVI announced today the award of up to US$126 million from the Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services to develop two recombinant vesicular stomatitis virus (rVSV)-vectored filovirus vaccine candidates. This award supports preclinical activities and includes options for…

https://www.iavi.org/press-release/iavi-and-the-biomedical-advanced-research-and-development-authority-partner-to-advance-filovirus-vaccine-candidates/

Press Releases

EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development

June 15, 2021

Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access.

https://www.iavi.org/press-release/edctp-and-cepi-funding-moves-iavis-lassa-fever-vaccine-candidate-into-advanced-clinical-development/

Features

IAVI announces termination of the PEPFAR-funded ADVANCE program and staff reductions

February 27, 2025

ADVANCE produced a legacy of achievement in the search for an HIV vaccine.

https://www.iavi.org/features/iavi-announces-termination-of-the-pepfar-funded-advance-program/

Features

Meet the Scientist: Dr. Gaudensia Mutua on IAVI’s Lassa fever vaccine development program

December 20, 2024

Gaudensia Mutua, a medical director with IAVI in Nairobi, Kenya, discusses her work in support of IAVI’s Lassa fever vaccine program.

https://www.iavi.org/features/meet-the-scientist-dr-gaudensia-mutua-on-iavis-lassa-fever-vaccine-development-program/

IAVI Report

TB vaccines: Achievable not aspirational

December 5, 2024

The 7th Global Forum on TB Vaccines stoked optimism but raised questions about how the field can optimize efforts to introduce new vaccines this decade.

https://www.iavi.org/iavi-report/tb-vaccines-achievable-not-aspirational/

Features

Outthinking and outsmarting HIV to outdo an epidemic

December 3, 2024

Can we outsmart a virus so clever and evasive that it has challenged scientists for decades? My research seeks answers to these pressing questions.

https://www.iavi.org/features/outthinking-and-outsmarting-hiv-to-outdo-an-epidemic/

Pages

An Africa-led Partnership

https://www.iavi.org/advance-draft/africa-led-partnership-draft/

IAVI Report

A data-driven approach to sequencing HIV vaccine immunogens

October 4, 2024

Discovery medicine trials are underway to evaluate several HIV vaccine immunogens designed to prime the immune system to make broadly neutralizing antibodies. What comes next?

https://www.iavi.org/iavi-report/a-data-driven-approach-to-sequencing-hiv-vaccine-immunogens/

Press Releases

Africa CDC and IAVI sign Memorandum of Understanding to enhance vaccine and antibody research capacity in Africa

September 25, 2024

Partnership also to include efforts to strengthen the continent's disease-fighting capacity, pandemic readiness, and supply resilience.

https://www.iavi.org/press-release/iavi-africa-cdc-sign-mou/

IAVI Report

Facing stubborn manufacturing challenges

September 16, 2024

Manufacturing proteins is notoriously expensive and complex. Will new ways of producing them come from continuous processes, Sunflowers, or even…goat milk?

https://www.iavi.org/iavi-report/facing-stubborn-challenges-in-vaccine-manufacturing/